雪榕生物(300511.SZ)：成都雪榕拟设立控股子公司成都雪草

Core Viewpoint - Xuerong Biotechnology (300511.SZ) is establishing a new company, Chengdu Xuesao Biotechnology Co., Ltd., to enhance production capacity utilization and optimize product structure through a multi-variety layout strategy [1] Group 1: Company Investment and Structure - Chengdu Xuesao will be jointly funded by Chengdu Xuerong, Qinghai Chenxin Biotechnology Co., Ltd., and Mr. Zheng Weidong, with a registered capital of 20 million yuan [1] - Chengdu Xuerong will contribute 10.2 million yuan, holding a 51% stake, while Chenxin Biotechnology will contribute 7 million yuan for a 35% stake, and Mr. Zheng will invest 2.8 million yuan for a 14% stake [1] - The primary focus of Chengdu Xuesao will be on the research, cultivation, and sales of Cordyceps sinensis [1]